Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.4 EUR
15.90 M EUR
1.05 B EUR
54.12 M
About LivaNova PLC
Sector
Industry
CEO
Vladimir A. Makatsaria
Website
Headquarters
London
Founded
2015
ISIN
GB00BYMT0J19
FIGI
BBG009THVQC6
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LIVANOVA PLC DL -,01 stocks are traded under the ticker LIA.
We've gathered analysts' opinions on LIVANOVA PLC DL -,01 future price: according to them, LIA price has a max estimate of 76.10 EUR and a min estimate of 55.17 EUR. Watch LIA chart and read a more detailed LIVANOVA PLC DL -,01 stock forecast: see what analysts think of LIVANOVA PLC DL -,01 and suggest that you do with its stocks.
Yes, you can track LIVANOVA PLC DL -,01 financials in yearly and quarterly reports right on TradingView.
LIVANOVA PLC DL -,01 is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LIA earnings for the last quarter are 0.78 EUR per share, whereas the estimation was 0.77 EUR resulting in a 1.17% surprise. The estimated earnings for the next quarter are 0.72 EUR per share. See more details about LIVANOVA PLC DL -,01 earnings.
LIVANOVA PLC DL -,01 revenue for the last quarter amounts to 310.85 M EUR, despite the estimated figure of 313.11 M EUR. In the next quarter, revenue is expected to reach 289.03 M EUR.
LIA net income for the last quarter is 54.00 M EUR, while the quarter before that showed 29.60 M EUR of net income which accounts for 82.45% change. Track more LIVANOVA PLC DL -,01 financial stats to get the full picture.
No, LIA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 26, 2025, the company has 2.90 K employees. See our rating of the largest employees — is LIVANOVA PLC DL -,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LIVANOVA PLC DL -,01 EBITDA is 199.02 M EUR, and current EBITDA margin is 17.56%. See more stats in LIVANOVA PLC DL -,01 financial statements.
Like other stocks, LIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIVANOVA PLC DL -,01 stock right from TradingView charts — choose your broker and connect to your account.